Literature DB >> 9306653

Multivalent vaccines: prospects and challenges.

R E Spier1.   

Abstract

The advantages and disadvantages of combination vaccines are set out with a clear indication that, although there are many (described and discussed) influences on in the immunogenicity of a vaccine it would still be of considerable value to be able to deliver such materials with the minimum number of needle-stick injections. Such a situation may become facilitated in the future as vaccines based on plasmid DNA become available; a prospect which is examined in outline in the final section.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9306653     DOI: 10.1007/BF02898716

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.629


  11 in total

1.  Protection of cattle against foot-and-mouth disease by a synthetic peptide.

Authors:  R DiMarchi; G Brooke; C Gale; V Cracknell; T Doel; N Mowat
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

2.  Combination vaccines: regulatory issues.

Authors:  D K McClintock
Journal:  Ann N Y Acad Sci       Date:  1995-05-31       Impact factor: 5.691

3.  Immune responses to pertussis vaccines concurrently administered with viral vaccines.

Authors:  S A Halperin; B J Eastwood; J M Langley
Journal:  Ann N Y Acad Sci       Date:  1995-05-31       Impact factor: 5.691

4.  Utility of large-linked databases in vaccine safety, particularly in distinguishing independent and synergistic effects. The Vaccine Safety Datalink Investigators.

Authors:  S G Wassilak; J W Glasser; R T Chen; S C Hadler
Journal:  Ann N Y Acad Sci       Date:  1995-05-31       Impact factor: 5.691

5.  A perspective on issues relating to future vaccines.

Authors:  B R Bloom
Journal:  Ann N Y Acad Sci       Date:  1995-05-31       Impact factor: 5.691

6.  Practical considerations regarding the impact on immunization schedules of the introduction of new combined vaccines.

Authors:  N A Halsey
Journal:  Ann N Y Acad Sci       Date:  1995-05-31       Impact factor: 5.691

7.  Combined Vaccines and Simultaneous Administration: Current Issues and Perspectives. Conference proceedings. Bethesda, Maryland, July 28-30, 1993.

Authors: 
Journal:  Ann N Y Acad Sci       Date:  1995-05-31       Impact factor: 5.691

8.  Report of a meeting on "Vaccines; new technologies and applications".

Authors:  R E Spier
Journal:  Vaccine       Date:  1995-08       Impact factor: 3.641

9.  Direct gene transfer into mouse muscle in vivo.

Authors:  J A Wolff; R W Malone; P Williams; W Chong; G Acsadi; A Jani; P L Felgner
Journal:  Science       Date:  1990-03-23       Impact factor: 47.728

10.  Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination.

Authors:  R W Sutter; M A Pallansch; L A Sawyer; S L Cochi; S C Hadler
Journal:  Ann N Y Acad Sci       Date:  1995-05-31       Impact factor: 5.691

View more
  2 in total

1.  Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV.

Authors:  Chih-Wei Lin; Ching-Yun Chang; Wei-Lin Chen; Shih-Chang Lin; Chien-Chun Liao; Jui-Yuan Chang; Chia-Chyi Liu; Alan Yung-Chih Hu; Tsung-Chun Lu; Ai-Hsiang Chou; Suh-Chin Wu; Pele Chong; Ming-Hsi Huang
Journal:  Hum Vaccin Immunother       Date:  2013-07-09       Impact factor: 3.452

2.  Multivalent fusion protein vaccine for lymphatic filariasis.

Authors:  Gajalakshmi Dakshinamoorthy; Abhilash Kumble Samykutty; Gnanasekar Munirathinam; Maryada Venkatarami Reddy; Ramaswamy Kalyanasundaram
Journal:  Vaccine       Date:  2012-10-02       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.